Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Billups

Concepts (289)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
19
2025
240
4.470
 Why?
Osteoporosis
4
2023
236
2.230
 Why?
Hypertension
9
2026
1264
1.920
 Why?
Primary Health Care
14
2026
1734
1.810
 Why?
Remote Consultation
2
2026
66
1.730
 Why?
Osteoporotic Fractures
3
2023
61
1.580
 Why?
Bone Density Conservation Agents
4
2022
81
1.540
 Why?
Quality Improvement
4
2026
1291
1.500
 Why?
Osteoporosis, Postmenopausal
3
2022
40
1.160
 Why?
Gout Suppressants
2
2025
20
1.010
 Why?
Gout
2
2025
35
0.990
 Why?
Pharmaceutical Services
7
2020
78
0.960
 Why?
Antihypertensive Agents
5
2025
511
0.950
 Why?
Dermatologists
1
2025
7
0.940
 Why?
Acne Vulgaris
1
2025
25
0.920
 Why?
Xanthine Oxidase
1
2025
79
0.900
 Why?
Drug Costs
2
2025
116
0.900
 Why?
Dermatologic Agents
1
2025
68
0.890
 Why?
Rheumatic Diseases
1
2026
97
0.860
 Why?
Rheumatology
1
2026
133
0.840
 Why?
Blood Pressure Determination
3
2026
144
0.830
 Why?
Medicare Part C
1
2025
31
0.830
 Why?
Guideline Adherence
4
2025
589
0.790
 Why?
Physicians, Primary Care
1
2025
207
0.770
 Why?
Pharmacy Service, Hospital
11
2017
81
0.750
 Why?
Blood Pressure
3
2025
1769
0.750
 Why?
Maternal Health Services
1
2024
102
0.740
 Why?
Practice Patterns, Physicians'
5
2025
1358
0.740
 Why?
Enzyme Inhibitors
2
2025
826
0.730
 Why?
Retrospective Studies
25
2025
17101
0.730
 Why?
Medication Adherence
2
2025
539
0.700
 Why?
Drug Monitoring
8
2015
395
0.680
 Why?
Urinary Tract Infections
1
2023
203
0.680
 Why?
Communicable Diseases
1
2023
163
0.670
 Why?
Aged
37
2026
25947
0.640
 Why?
Pre-Exposure Prophylaxis
1
2023
246
0.640
 Why?
Patient-Centered Care
1
2024
544
0.580
 Why?
Emergency Service, Hospital
5
2023
2313
0.550
 Why?
Cohort Studies
11
2025
5965
0.540
 Why?
Female
48
2026
78376
0.530
 Why?
Diphosphonates
2
2015
68
0.530
 Why?
Health Services Accessibility
1
2026
1099
0.520
 Why?
Patient Transfer
1
2020
206
0.510
 Why?
Education, Pharmacy, Graduate
2
2016
12
0.510
 Why?
Middle Aged
30
2026
35928
0.510
 Why?
Blood Pressure Monitoring, Ambulatory
2
2014
68
0.500
 Why?
Humans
61
2026
144957
0.500
 Why?
Pharmacy Residencies
1
2016
8
0.480
 Why?
Community Pharmacy Services
2
2013
46
0.480
 Why?
Colorado
11
2026
4564
0.470
 Why?
Research
2
2016
431
0.460
 Why?
Anti-HIV Agents
1
2023
888
0.460
 Why?
Male
43
2026
72406
0.450
 Why?
Aged, 80 and over
11
2025
8279
0.430
 Why?
Telephone
1
2015
175
0.410
 Why?
Hospitals, Veterans
9
2001
259
0.400
 Why?
Pharmacies
1
2014
42
0.400
 Why?
Correspondence as Topic
2
2015
16
0.390
 Why?
Patient Compliance
5
2009
589
0.380
 Why?
Patient Satisfaction
5
2013
705
0.380
 Why?
Adult
19
2026
40506
0.370
 Why?
Health Maintenance Organizations
4
2014
105
0.360
 Why?
Professional Role
5
2020
158
0.360
 Why?
Prescription Drugs
1
2013
111
0.360
 Why?
Delivery of Health Care, Integrated
5
2018
299
0.340
 Why?
Insurance, Health
1
2014
303
0.340
 Why?
Cost Savings
2
2015
86
0.330
 Why?
Neuromuscular Agents
1
2011
45
0.320
 Why?
Drug Prescriptions
4
2020
285
0.310
 Why?
Drug Therapy
2
2000
80
0.300
 Why?
Nortriptyline
1
2009
9
0.300
 Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2009
4
0.300
 Why?
Amitriptyline
1
2009
24
0.290
 Why?
Antidepressive Agents, Tricyclic
1
2009
31
0.290
 Why?
Antidepressive Agents, Second-Generation
1
2009
44
0.290
 Why?
United States
16
2026
15988
0.280
 Why?
Referral and Consultation
2
2026
853
0.280
 Why?
Tetrahydronaphthalenes
2
1998
31
0.280
 Why?
Perception
2
2023
377
0.270
 Why?
HIV Infections
1
2023
3154
0.270
 Why?
Calcium Channel Blockers
2
1998
165
0.260
 Why?
Health Knowledge, Attitudes, Practice
1
2016
1416
0.260
 Why?
Electronic Health Records
4
2026
1177
0.250
 Why?
Benzimidazoles
2
1998
190
0.250
 Why?
Fractures, Bone
1
2012
415
0.250
 Why?
Cholesterol, LDL
2
2025
358
0.240
 Why?
Managed Care Programs
2
2013
140
0.240
 Why?
Pilot Projects
2
2023
1890
0.230
 Why?
Lovastatin
1
2005
37
0.230
 Why?
American Heart Association
2
2020
350
0.230
 Why?
Simvastatin
1
2005
60
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2018
257
0.220
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2025
439
0.210
 Why?
Heart Diseases
1
2008
350
0.210
 Why?
Uric Acid
1
2025
166
0.210
 Why?
Health Care Costs
2
2014
427
0.210
 Why?
Patient Acceptance of Health Care
2
2023
886
0.210
 Why?
Academic Medical Centers
2
2024
548
0.200
 Why?
Bone Density
2
2022
482
0.200
 Why?
Ambulatory Care
6
2010
603
0.200
 Why?
Cholesterol
2
2020
408
0.200
 Why?
Young Adult
6
2025
14126
0.200
 Why?
Migraine Disorders
2
2020
112
0.200
 Why?
Gastrointestinal Hemorrhage
1
2024
136
0.190
 Why?
Absorptiometry, Photon
1
2023
276
0.190
 Why?
Wounds and Injuries
1
2011
957
0.190
 Why?
Denosumab
1
2022
10
0.180
 Why?
Patient Care Team
3
2024
689
0.180
 Why?
Program Evaluation
1
2026
949
0.170
 Why?
Practice Guidelines as Topic
3
2020
1563
0.170
 Why?
Serotonin 5-HT1 Receptor Agonists
1
2020
3
0.170
 Why?
Atherosclerosis
1
2025
409
0.170
 Why?
Aspirin
1
2024
400
0.160
 Why?
Pregnancy Outcome
1
2024
476
0.160
 Why?
Diabetes Mellitus
2
2013
1098
0.160
 Why?
Analgesics, Opioid
2
2020
1143
0.160
 Why?
Adolescent
5
2025
22453
0.150
 Why?
Quality of Health Care
1
2024
693
0.150
 Why?
Glucocorticoids
1
2023
535
0.140
 Why?
Student Health Services
1
2018
15
0.140
 Why?
Lithium Compounds
1
2018
11
0.140
 Why?
Pregnancy Complications
1
2024
592
0.140
 Why?
Antimanic Agents
1
2018
19
0.140
 Why?
Angina Pectoris
1
1998
75
0.140
 Why?
Product Surveillance, Postmarketing
1
1998
73
0.140
 Why?
Drug Approval
1
1998
91
0.130
 Why?
Cardiovascular Diseases
3
2025
2171
0.130
 Why?
Preceptorship
1
2018
67
0.130
 Why?
Data Collection
4
2014
635
0.130
 Why?
Antidepressive Agents
2
2017
248
0.130
 Why?
Students, Pharmacy
1
2018
96
0.130
 Why?
Drug Interactions
4
2012
401
0.130
 Why?
Quality of Life
4
2001
3192
0.120
 Why?
Pharmaceutical Preparations
2
2016
170
0.110
 Why?
Administration, Oral
2
2015
848
0.110
 Why?
Monitoring, Physiologic
1
2017
289
0.110
 Why?
Antipsychotic Agents
1
2017
214
0.110
 Why?
Internship, Nonmedical
1
2015
10
0.110
 Why?
Cost-Benefit Analysis
2
2015
636
0.110
 Why?
Hematinics
1
2014
22
0.110
 Why?
Patient Readmission
1
2020
759
0.110
 Why?
Risk Factors
10
2025
10792
0.110
 Why?
Renal Insufficiency
2
2015
169
0.100
 Why?
United States Department of Veterans Affairs
5
2001
768
0.100
 Why?
Follow-Up Studies
3
2013
5417
0.100
 Why?
Reminder Systems
1
2015
141
0.100
 Why?
Patient Discharge
1
2020
983
0.100
 Why?
Educational Measurement
1
2016
326
0.100
 Why?
Colchicine
1
2012
21
0.090
 Why?
Anti-Bacterial Agents
1
2023
1915
0.090
 Why?
Anemia
1
2014
188
0.090
 Why?
Outpatients
1
2016
443
0.090
 Why?
Lipids
1
2017
710
0.090
 Why?
Hematologic Diseases
1
2012
66
0.090
 Why?
Decision Support Systems, Clinical
1
2016
265
0.090
 Why?
Diagnosis, Computer-Assisted
1
2013
91
0.090
 Why?
Health Expenditures
1
2014
194
0.090
 Why?
Cross-Sectional Studies
4
2024
5872
0.090
 Why?
Drug Therapy, Combination
2
2009
1048
0.090
 Why?
Hyperlipidemias
3
2017
122
0.090
 Why?
Hospitalization
2
2018
2434
0.080
 Why?
Evaluation Studies as Topic
1
2011
166
0.080
 Why?
Job Satisfaction
1
2013
240
0.080
 Why?
Chemical and Drug Induced Liver Injury
1
2012
139
0.080
 Why?
Pregnancy
1
2024
7191
0.080
 Why?
Venous Thromboembolism
1
2015
324
0.080
 Why?
Chronic Disease
4
2008
1813
0.080
 Why?
Diazepam
1
2010
33
0.080
 Why?
Amiodarone
1
2010
31
0.080
 Why?
Diabetes Mellitus, Type 2
2
2022
2584
0.080
 Why?
Anti-Anxiety Agents
1
2010
45
0.080
 Why?
Anticoagulants
1
2015
724
0.080
 Why?
Ipratropium
1
2009
4
0.080
 Why?
Case-Control Studies
3
2018
3608
0.080
 Why?
Depression
2
2017
1559
0.080
 Why?
Paroxetine
1
2009
10
0.070
 Why?
Anti-Arrhythmia Agents
1
2010
142
0.070
 Why?
Cytochrome P-450 CYP2D6
1
2009
32
0.070
 Why?
Bupropion
1
2009
47
0.070
 Why?
Mental Disorders
1
2018
1172
0.070
 Why?
Heart Failure
1
2022
2323
0.070
 Why?
Mibefradil
2
1998
9
0.070
 Why?
Fluoxetine
1
2009
54
0.070
 Why?
Time Factors
4
2013
7183
0.070
 Why?
Bronchodilator Agents
1
2009
183
0.070
 Why?
Kidney
1
2016
1496
0.070
 Why?
Fees, Pharmaceutical
1
2008
8
0.070
 Why?
Telemedicine
1
2017
948
0.070
 Why?
Internet
1
2013
700
0.070
 Why?
Prospective Studies
5
2015
7997
0.060
 Why?
Blood Glucose
1
2017
2330
0.060
 Why?
Surveys and Questionnaires
7
2018
6053
0.060
 Why?
Sumatriptan
1
2006
6
0.060
 Why?
Tryptamines
1
2006
5
0.060
 Why?
Serotonin Receptor Agonists
1
2006
27
0.060
 Why?
Financing, Personal
1
2005
27
0.060
 Why?
Drugs, Generic
1
2005
27
0.060
 Why?
Hypolipidemic Agents
2
2008
88
0.060
 Why?
Dose-Response Relationship, Drug
1
2009
2032
0.050
 Why?
Triazoles
1
2006
184
0.050
 Why?
Incidence
1
2011
2883
0.050
 Why?
Patients
1
2005
182
0.050
 Why?
Anticholesteremic Agents
1
2005
154
0.050
 Why?
Medical Records Systems, Computerized
2
2006
95
0.050
 Why?
Age Factors
1
2011
3335
0.050
 Why?
Proton Pump Inhibitors
1
2024
109
0.050
 Why?
Mass Screening
1
2012
1348
0.050
 Why?
Medicaid
2
2017
462
0.050
 Why?
Sex Factors
1
2009
2114
0.050
 Why?
Secondary Prevention
1
2024
255
0.050
 Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2022
17
0.050
 Why?
Primary Prevention
1
2024
220
0.050
 Why?
Pulmonary Disease, Chronic Obstructive
1
2009
923
0.040
 Why?
Sodium
1
2022
197
0.040
 Why?
Economics, Pharmaceutical
1
2000
10
0.040
 Why?
Treatment Outcome
3
2006
11695
0.040
 Why?
Platelet Aggregation Inhibitors
1
2024
497
0.040
 Why?
Medication Systems, Hospital
1
1999
6
0.040
 Why?
Ambulatory Care Facilities
2
2017
266
0.040
 Why?
Federal Government
1
2018
23
0.030
 Why?
Community Health Centers
1
2018
59
0.030
 Why?
Veterans
2
2001
1603
0.030
 Why?
Outpatient Clinics, Hospital
1
1998
80
0.030
 Why?
Renal Insufficiency, Chronic
2
2014
653
0.030
 Why?
Vulnerable Populations
1
2018
177
0.030
 Why?
Glucose
1
2022
1049
0.030
 Why?
Software
2
1999
692
0.030
 Why?
Counseling
1
2000
408
0.030
 Why?
Drug Dosage Calculations
1
2016
27
0.030
 Why?
Contraindications
1
2016
91
0.030
 Why?
Prescription Drug Misuse
1
2017
51
0.030
 Why?
Health Status
1
2001
836
0.030
 Why?
International Normalized Ratio
1
2015
49
0.030
 Why?
Logistic Models
1
2000
2119
0.030
 Why?
Epoetin Alfa
1
2014
9
0.030
 Why?
Warfarin
1
2015
170
0.030
 Why?
Longitudinal Studies
2
2014
2947
0.030
 Why?
Publishing
1
2015
114
0.020
 Why?
Erythropoietin
1
2014
100
0.020
 Why?
Clinical Trials as Topic
1
1998
1054
0.020
 Why?
Pain Management
1
2017
405
0.020
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
 Why?
Drug Overdose
1
2017
370
0.020
 Why?
Acute Disease
1
2015
1031
0.020
 Why?
Cytochrome P-450 CYP3A
1
2012
93
0.020
 Why?
Chi-Square Distribution
1
2013
529
0.020
 Why?
Specialization
1
2013
136
0.020
 Why?
Insurance, Health, Reimbursement
1
2012
97
0.020
 Why?
Recurrence
1
2015
1135
0.020
 Why?
Education, Pharmacy
1
2013
121
0.020
 Why?
Recombinant Proteins
1
2014
1371
0.020
 Why?
Commission on Professional and Hospital Activities
1
2010
4
0.020
 Why?
Hemorrhage
1
2015
809
0.020
 Why?
Thyrotropin
1
2010
118
0.020
 Why?
Alanine Transaminase
1
2010
151
0.020
 Why?
Nebulizers and Vaporizers
1
2009
62
0.020
 Why?
Data Interpretation, Statistical
2
2001
372
0.020
 Why?
Spirometry
1
2009
231
0.020
 Why?
Opioid-Related Disorders
1
2017
601
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Forced Expiratory Volume
1
2009
449
0.020
 Why?
Comorbidity
1
2013
1660
0.020
 Why?
Predictive Value of Tests
1
2013
2118
0.020
 Why?
Drug Utilization
1
2008
167
0.020
 Why?
Cardiology
1
2010
353
0.020
 Why?
Electrocardiography
1
2010
663
0.020
 Why?
Analgesics
1
2008
231
0.010
 Why?
Prevalence
1
2012
2836
0.010
 Why?
Prognosis
1
2013
4293
0.010
 Why?
Pain
1
2008
782
0.010
 Why?
Child, Preschool
1
2017
11799
0.010
 Why?
Total Quality Management
1
2001
57
0.010
 Why?
Reproducibility of Results
2
1999
3415
0.010
 Why?
Health Status Indicators
1
2001
166
0.010
 Why?
Quality-Adjusted Life Years
1
2000
121
0.010
 Why?
Lipoproteins, LDL
1
2000
119
0.010
 Why?
Treatment Refusal
1
2000
98
0.010
 Why?
Diabetes Complications
1
2001
223
0.010
 Why?
Multicenter Studies as Topic
1
2001
405
0.010
 Why?
Linear Models
1
2001
854
0.010
 Why?
Health Services Research
1
2001
396
0.010
 Why?
Medical Records
1
1999
189
0.010
 Why?
Quality Indicators, Health Care
1
2001
335
0.010
 Why?
Attitude to Health
1
2001
436
0.010
 Why?
Child
1
2017
22657
0.010
 Why?
Patient Education as Topic
1
2000
780
0.010
 Why?
Randomized Controlled Trials as Topic
1
2001
1721
0.010
 Why?
Sensitivity and Specificity
1
1999
1990
0.010
 Why?
Severity of Illness Index
1
1999
2925
0.010
 Why?
Billups's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (289) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)